KFGK
EDIT icon

Keystone Financial Group (Kentucky)’s Editas Medicine EDIT Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Hold
14,050
– – ﹤0.01% 556
2026
Q1 		$34.7K Hold
14,050
– – ﹤0.01% 515
2025
Q4 		$28.8K Buy
+14,050
New +$40.6K ﹤0.01% 452
2025
Q3 		– Sell
-14,000
Closed -$30.8K – 439
2025
Q2 		$30.8K Hold
14,000
– – ﹤0.01% 425
2025
Q1 		$16.2K Hold
14,000
– – ﹤0.01% 394
2024
Q4 		$17.8K Hold
14,000
– – ﹤0.01% 390
2024
Q3 		$47.7K Buy
+14,000
New +$60.9K 0.01% 369
2024
Q2 		– Sell
-14,000
Closed -$104K – 193
2024
Q1 		$104K Hold
14,000
– – 0.02% 342
2023
Q4 		$142K Hold
14,000
– – 0.02% 290
2023
Q3 		$109K Hold
14,000
– – 0.02% 295
2023
Q2 		$115K Buy
+14,000
New +$122K 0.02% 296
2022
Q4 		$124K Hold
14,000
– – 0.02% 275
2022
Q3 		$171K Hold
14,000
– – 0.03% 268
2022
Q2 		$166K Buy
+14,000
New +$188K 0.03% 278

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s EDIT Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) held its Editas Medicine (EDIT) position steady in Q2 2026 at 14,050 shares worth $45.5K. The position accounts for ﹤0.01% of the portfolio, ranked #556.

Keystone Financial Group (Kentucky) first reported a position in EDIT in Q2 2022 and has held it in 14 quarters since. The position peaked at $171K in Q3 2022. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 14,050 shares of Editas Medicine worth $45.5K as of Q2 2026.
  • Keystone Financial Group (Kentucky) left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #556 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Editas Medicine in Q2 2022 and has held it in 14 quarters since.
  • Keystone Financial Group (Kentucky)'s Editas Medicine position peaked at $171K in Q3 2022.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.